Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Trelagliptin succinate (SYR-472 succinate) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2D).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 39.00 | |
10 mg | In stock | $ 64.00 | |
25 mg | In stock | $ 82.00 | |
50 mg | In stock | $ 97.00 | |
100 mg | In stock | $ 128.00 | |
500 mg | In stock | $ 323.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 43.00 |
Description | Trelagliptin succinate (SYR-472 succinate) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2D). |
Targets&IC50 | DPP4:4 nM |
Synonyms | SYR-472 succinate, SYR472 |
Molecular Weight | 475.47 |
Formula | C22H26FN5O6 |
CAS No. | 1029877-94-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (115.67 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Trelagliptin succinate 1029877-94-8 Proteases/Proteasome Ubiquitination Proteasome DPP-4 glycemic Diabete Anti-diabetic SYR 472 Succinate Zafatek Inhibitor SYR-472 Succinate SYR-472 succinate mellitus SYR 472 Trelagliptin inhibit SYR472 Dipeptidyl Peptidase SYR-472 Trelagliptin Succinate DPP SYR472 Succinate inhibitor